In Turkey, Ankaferd Blood Stopper ® (ABS) has been approved for the management of external haemorrhages and bleedings o ccurring during den tal surgeries (Goker et al., 200 8). A nkaferd co mprises a standardized m ixture of plants, including Thymus vulgaris, Glycyrrhiza glabra, Vitis vinifera, Alpinia officinarum, and Urtica diodica. This stud y aimed to evaluate the ef ficacy of AB S tam ponade in the contro l of intra-oper ative b leeding occurring during ad enoidectomy performed in children under th e age of 12. Sixty children were randomized to receive 1 to 5 m inute-tamponade with either ABS or topical gauze spong es soaked in saline solution (SS) d uring their ad enoidectomy.. Ti me-to-haemostasis and the number of packs required wer e recorded. A visual analog scale was used by the operating surgeon to record subjective data, including the rate of bleeding f ollowing the f irst adenoid pack removal (0= none, 3=brisk). Co mpared to the child ren in the SS group (n=30), time-to-haemostasis seen in ABS patients (n=30) was significantly shorter (mean ± standard deviation, 1.93 ± 1.39 m in vs 3 .20 ± 1.50 min; p<0.0001); they required a lower number of packs (m ean, 1.93 vs. 3.20), and appeared to bleed less (53.3% vs 6.7%; p=0.0001). ABS aids in the contro l of intra-operative bleeding and reduces the number of packs required to achieve h aemostasis, so th at it can be recommended f or tamponades per formed during paediatric adenoidectomies.
Introduction
Ankaferd Blood Stopper ® (ABS) is a m edicinal plant extr act which has previously been used in the Turkish traditional medicine as a haemostatic agent (Huri et al, 2009 ; Kurt et al, 2008) . Previous reports as to the safety and efficacy of this product have indicated its sterility and non-toxicity (Cipil et al, 2009; Goker et al, 2008; Bilgili et al, 2009 ; Kurt et al, 2009) . In this study, the ef ficacy o f AB S tamponade undertaken to contro l bleeding during ad enoidectomy, was com pared against that of the traditional tamponade achieved by topical application of gauze sponges soaked in saline solution.
Materials and Methods
A prospectiv e, non-randomized, non-blind ed ob servational study was condu cted in 60 con secutive children who underwent adenoidectomy between March 2009 and May 2009. Th e study was approved by the local Bo ard of Ethics. A written consent was obtained from the par ents of all pat ients prior to their inclusion. Each child was assigned either to the ABS or the SS group in order of appearan ce on the surgical waiting list. Th e pat ients wer e subj ected to the int ended procedure if having an upper airway obstruction due to adenoid tissue. Children younger than 3 or older than 12, and/or those suffering from haematological disorders, were excluded from the study.
All surger ies w ere perf ormed b y the sam e surgeon (H .Y.) under general anaesthesia achieved by endotracheal intubation. Ac cording to our s tudy protocol, e ach pat ient was placed in the Rose po sition; a Davis-Boy le mouth gag supported by Dr affin bipods was inserted in to the mouth. A tong ue retractor of a suitab le size was used depend ing on the patient's ag e. A denoidectomy was then p erformed us ing a cur ette and th e oper ative site w as p acked with e ither an ABS tamponade or a saline-soaked sponge gauze for 1 m in. Following a g entle removal of the tamponade, the bleeding control efficacy was evaluated by the operating surgeon by means of a visual analog scale (0= none, 3= brisk). The tamponade was switched at 1 m in intervals, as r equired. Children who persistently bled despite a 5 minute-tamponade were con sidered for additional haemostatic procedures (e.g. electrocauterisation).
Following the a ttainment of an absolute haem ostasis, Dav is-Boyle m outh gag w as removed and the patient was extubated. Acetam inophen was recommended for pain relief an d adm inistered as re quired. No antibiotics were prescrib ed routinely. The children were ex amined f or bleeding and discha rged on the f irst postop erative d ay. Data were a nalyzed by means of Chi-squared and Mann-Whitney-U tests using SPSS 15 software.
Results
No statistically significant differences in age and sex of the children c onstituting the two groups (p>0.05) we re revealed; the mean ages of the 30 children (19 male, 11 female) in the ABS group and the 30 children (16 male, 14 female) in the SS group we re 7.83 ± 3.17 yrs and 6.30 ± 2.56 y rs, respectively. In 16 ABS ( 53.3%) and two SS patients (6 .7%), intraoperative haemostasis was achieved after a single pack application (p=0.0001, Table 1 ). In 88.9% members of the ABS group and 11.1% members of the SS group, tim e-to-haemostasis equalled to 1 minute, which is statistically significant (p=0.0001; Table 2 ). The mean num ber of packs used in the ABS group and the SS group was 1.93, and 3.20 , respectively (p=0.0001). Electrocauterisation was used to achieve haemostasis in one child in the ABS group, and three children in the SS group. No major complications had been seen during or after the surgery in either group; the same goes f or early or late po stoperative bleedings or infections. 
Discussion
Adenoidectomy is on e of the m ost co mmonly perf ormed p rocedures in children , but b leeding f ollowing adenoidectomy may pose a s a c hallenge to a surgeon and m ay require the pl acement of a post erior n asopharyngeal pack followed by a subsequent prolonged hospitalisation (Mathiasen and Cruz, 2004) . Therefore, improvements in currently used techniques and innovations th at enable a m ore ef ficient bl eeding control dur ing and f ollowing adenoid ectomy would be welcomed.
An ideal haemostatic agent can be applied quickly, conveniently and accurately. It should work to stop even rap id bleeding from a vessel or organ without causing local injury or systemic effects. Furthermore, it should work equally well on the anticoagulated and non-anticoagulated patie nt. Tradition al electrical and mechanical m eans are still the m ainstay of haemorrhage control, but new h aemostatic technologies continue to emerge (de la Torre et al, 2007). Mechanical and active topical sealants and haemostatic agents are now available in different forms; these agents can be used in a variety of settings as adjuncts to the control of surgical bleeding (Spotnitz et al, 2007; Jo et al, 2007; Mathiasen and Cruz, 2004) .
As an adjunctive treatment undertaken to the end of haemorrhage control, ABS can be used only topically, and not systemically. It induces a rapid formation of an unique protein network in both plasm a and serum (Cipil et al, 200 9, Kurt et al, 2008) . Ther efore, this uniq ue m echanism of action provide s ABS with the advantage o ver other haemostatic p lant extracts. ABS can be ef fective in subj ects with norm al haem ostatic par ameters, as wel l as in those with prim ary and/or secondary haematological disord ers (Cipil et al., 2008) . In additio n to the phy siological haemostatic process, ABS exposure appears to enab le an incr eased tissu e oxy genation without affecting any individual clo tting f actor (Goker et al, 2008) . Shortening of the bleeding duration ach ieved by the app lication of topical ABS, suggests that the extract functions, at least partly, via m odulation of platelet f unctions (Cipil et al, 2008) . Other po ssible m echanisms of its action r equire f urther elucidation.
In our study we observed a statistically significantly shorter duration of bleeding and a statistically lower number of packs required to achieve ABS tam ponade-induced haemostasis during adenoidectomy as com pared to saline-soaked gauze sponge application. However, there were certain limitations to this study. Firstly, ABS tamponade is a pack so aked by 10 ml of ABS solution, which was applied in all adenoidectomy cavities. The optimal dosage of ABS is not certain. Secondly, ABS ampoules that contain 2 ml of the agent may be more beneficial topically within the surgical field as a higher proportion may be appropriately delivered in a more cost-effective manner. Thirdly, ABS is avail able in form of hae mostatic spray which could be u seful for surgeries su ch as adeno idectomy. In conc lusion, f urther clinical stud ies ar e recomm ended in order to demonstrate any long-term haemostatic effects or potential toxicities of ABS.
